Rationale for targeting complement in COVID-19. (2020)

First Author: Polycarpou A
Attributed to:  A flow cytometry facility for ocular regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202012642

PubMed Identifier: 32559343

Publication URI: http://europepmc.org/abstract/MED/32559343

Type: Journal Article/Review

Volume: 12

Parent Publication: EMBO molecular medicine

Issue: 8

ISSN: 1757-4676